Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  35 results for ""Humans""

Your Filters

Publication : diabetes technology therapeutics Subject : diabetes mellitus, type 2 Subject : glucose intolerance Geographic : texas Geographic : united states Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Insulin sensitivity and secretion in Arab Americans with glucose intolerance.

  • Authors : Salinitri FD; 1 Department of Pharmacy Practice, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences , Detroit, Michigan.; Pinelli NR

Subjects: Arabs*/Arabs*/Arabs*/statistics & numerical data ; Insulin Resistance*; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2013 Dec; Vol. 15 (12), pp. 1019-24. Date of Electronic Publication: 2013 Aug 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes.

  • Authors : Garg SK; Barbara Davis Center for Diabetes, Department of Medicine and Pediatrics, University of Colorado Denver, Aurora, Colorado, USA.; Kaur G

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/complications ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Mar; Vol. 26 (3), pp. 184-189.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.

  • Authors : Ebekozien O; Office of Chief Medical Officer, T1D Exchange, Boston, Massachusetts, USA.; School of Population Health, University of Mississippi, Jackson, Mississippi, USA.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*; Adult

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Nov; Vol. 25 (11), pp. 765-773. Date of Electronic Publication: 2023 Oct 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations.

  • Authors : Forlenza GP; Barbara Davis Center, Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Denver, Denver, Colorado, USA.; Carlson AL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Nov; Vol. 24 (11), pp. 814-823. Date of Electronic Publication: 2022 Jul 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion.

  • Authors : Aleppo G; Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Parkin CG

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Aged ; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2021 Oct; Vol. 23 (10), pp. 715-725. Date of Electronic Publication: 2021 Jun 17.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring.

  • Authors : Galindo RJ; Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Diabetes Metabolism Research Emory University Hospital Midtown, Atlanta, Georgia, USA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Medicaid*; Aged

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2021 Sep; Vol. 23 (9), pp. 652-660. Date of Electronic Publication: 2021 Apr 27.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Evaluating the Performance of the Indian Diabetes Risk Score in Different Ethnic Groups.

  • Authors : Nugawela MD; UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom.; Sivaprasad S

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*ethnology ; Ethnicity/Ethnicity/Ethnicity/*statistics & numerical data ; Risk Assessment/Risk Assessment/Risk Assessment/*ethnology

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2020 Apr; Vol. 22 (4), pp. 285-300.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*analysis ; Blood Glucose Self-Monitoring/Blood Glucose Self-Monitoring/Blood Glucose Self-Monitoring/*instrumentation ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*blood

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2019 Dec; Vol. 21 (12), pp. 677-681. Date of Electronic Publication: 2019 Aug 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.

  • Authors : McCoy RG; Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.; Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Subjects: Practice Patterns, Physicians'*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2019 Dec; Vol. 21 (12), pp. 702-712. Date of Electronic Publication: 2019 Oct 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

  • Authors : Kazemian P; 1 Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts.; 2 Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts.

Subjects: Diabetes Mellitus, Type 2* ; Models, Statistical*; Computer Simulation/Computer Simulation/Computer Simulation/*standards

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2019 Jun; Vol. 21 (6), pp. 344-355.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  35 results for ""Humans""